IL-33 Independently Induces Eosinophilic Pericarditis and Cardiac Dilation: ST2 Improves Cardiac Function
暂无分享,去创建一个
W. Mitzner | D. Čiháková | D. Fairweather | K. Gabrielson | Michael J. Coronado | D. Bedja | D. Georgakopoulos | Jessica E. Brandt | Adriana Bucek | E. Abston | J. Barin | Joseph B. Kim | Michael Coronado
[1] W. Mitzner,et al. Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n. , 2012, American journal of physiology. Heart and circulatory physiology.
[2] Sandeep Sagar,et al. Myocarditis , 2012, The Lancet.
[3] D. Fairweather,et al. Biomarkers of Heart Failure in Myocarditis and Dilated Cardiomyopathy , 2011 .
[4] W. Mitzner,et al. Th2 Regulation of Viral Myocarditis in Mice: Different Roles for TLR3 versus TRIF in Progression to Chronic Disease , 2011, Clinical & developmental immunology.
[5] Ashley M. Miller,et al. The IL-33/ST2 pathway--A new therapeutic target in cardiovascular disease. , 2011, Pharmacology & therapeutics.
[6] T. Guilarte,et al. The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male mice , 2011, Biology of Sex Differences.
[7] D. Mozaffarian,et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.
[8] S. Kunkel,et al. Interleukin-33 contributes to both M1 and M2 chemokine marker expression in human macrophages , 2010, BMC Immunology.
[9] M. Kimura,et al. Mechanisms of IFNγ regulation of autoimmune myocarditis. , 2010, Experimental and molecular pathology.
[10] F. Liew,et al. IL-33 Exacerbates Eosinophil-Mediated Airway Inflammation , 2010, The Journal of Immunology.
[11] Noel R. Rose,et al. Proinflammatory cytokines in heart failure: double-edged swords , 2010, Heart Failure Reviews.
[12] C. Fiocchi,et al. Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis , 2010, Proceedings of the National Academy of Sciences.
[13] Y. Iwakura,et al. Interleukin-17A Is Dispensable for Myocarditis but Essential for the Progression to Dilated Cardiomyopathy , 2010, Circulation research.
[14] S. Kische,et al. Cardiac manifestation of the hypereosinophilic syndrome: new insights , 2010, Clinical Research in Cardiology.
[15] Peter Natesan Pushparaj,et al. IL-33 Exacerbates Autoantibody-Induced Arthritis , 2010, The Journal of Immunology.
[16] I. McInnes,et al. Disease-associated functions of IL-33: the new kid in the IL-1 family , 2010, Nature Reviews Immunology.
[17] M. Klapholz,et al. Acute eosinophilic myocarditis: Diagnosis and treatment , 2010, Acute cardiac care.
[18] M. Hayakawa,et al. Increased Levels of Interleukin 33 in Sera and Synovial Fluid from Patients with Active Rheumatoid Arthritis , 2010, The Journal of Rheumatology.
[19] Q. Tang,et al. The effects of NK4 on viral myocarditis mice. , 2009, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[20] Richard T. Lee,et al. Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 Signaling , 2009, Circulation. Heart failure.
[21] U. Eriksson,et al. Myeloid Differentiation Factor-88/Interleukin-1 Signaling Controls Cardiac Fibrosis and Heart Failure Progression in Inflammatory Dilated Cardiomyopathy , 2009, Circulation research.
[22] C. Dahinden,et al. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. , 2009, Blood.
[23] I. McInnes,et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells , 2008, Proceedings of the National Academy of Sciences.
[24] Pál Pacher,et al. Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats , 2008, Nature Protocols.
[25] B. McManus,et al. Ablation of Matrix Metalloproteinase-9 Increases Severity of Viral Myocarditis in Mice , 2008, Circulation.
[26] Ashley M. Miller,et al. IL-33 reduces the development of atherosclerosis , 2008, The Journal of experimental medicine.
[27] N. Rose,et al. Cutting Edge: Cross-Regulation by TLR4 and T cell Ig Mucin-3 Determines Sex Differences in Inflammatory Heart Disease1 , 2007, The Journal of Immunology.
[28] Richard T. Lee,et al. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. , 2007, The Journal of clinical investigation.
[29] M. Teixeira,et al. ST2, an IL‐1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion , 2007, Journal of leukocyte biology.
[30] J Fernando Bazan,et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.
[31] J. Hawiger,et al. Interactive Sites in the MyD88 Toll/Interleukin (IL) 1 Receptor Domain Responsible for Coupling to the IL1β Signaling Pathway* , 2005, Journal of Biological Chemistry.
[32] S. Prabhu. Cytokine-Induced Modulation of Cardiac Function , 2004, Circulation research.
[33] D. Kass,et al. Novel Model of Constrictive Pericarditis Associated With Autoimmune Heart Disease in Interferon-γ–Knockout Mice , 2004, Circulation.
[34] N. Rose,et al. IL-12 Receptor β1 and Toll-Like Receptor 4 Increase IL-1β- and IL-18-Associated Myocarditis and Coxsackievirus Replication1 , 2003, The Journal of Immunology.
[35] Richard T. Lee,et al. Identification of Serum Soluble ST2 Receptor as a Novel Heart Failure Biomarker , 2003, Circulation.
[36] A. Takeshita,et al. Disruption of Inducible Nitric Oxide Synthase Improves &bgr;-Adrenergic Inotropic Responsiveness but Not the Survival of Mice With Cytokine-Induced Cardiomyopathy , 2002, Circulation research.
[37] Michael J. Zilliox,et al. Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. , 2001, The American journal of pathology.
[38] W. Abraham,et al. Alterations in Adrenergic Receptor Signaling in Heart Failure , 2000, Heart Failure Reviews.
[39] P. Huang,et al. Modulation of mouse cardiac function in vivo by eNOS and ANP. , 2000, American journal of physiology. Heart and circulatory physiology.
[40] F. Clubb,et al. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. , 1998, Circulation.
[41] J. Lorenz,et al. Measurement of intraventricular pressure and cardiac performance in the intact closed-chest anesthetized mouse. , 1997, The American journal of physiology.
[42] H. Oral,et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). , 1996, Journal of the American College of Cardiology.
[43] A. Herskowitz,et al. Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis. , 1993, Journal of immunology.
[44] C. Natanson,et al. Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. , 1992, The American journal of physiology.
[45] J. O’Connell. The role of myocarditis in end-stage dilated cardiomyopathy. , 1987, Texas Heart Institute journal.
[46] N. Rose,et al. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. , 2007, Methods.
[47] N. Rose,et al. Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus‐induced myocarditis , 2005, Reviews in medical virology.
[48] N. Rose,et al. Interferon- Protects against Chronic Viral Myocarditis by Reducing Mast Cell Degranulation, Fibrosis, and the Profibrotic Cytokines Transforming Growth Factor- 1, Interleukin-1 , and Interleukin-4 in the Heart , 2004 .
[49] D. Kass,et al. Protocols for hemodynamic assessment of transgenic mice in vivo. , 2003, Methods in molecular biology.
[50] S. Liu,et al. Suppression of beta-adrenergic responsiveness of L-type Ca2+ current by IL-1beta in rat ventricular myocytes. , 1999, The American journal of physiology.
[51] R. Kennedy,et al. Suppression of β-adrenergic responsiveness of L-type Ca2+ current by IL-1β in rat ventricular myocytes. , 1999, American journal of physiology. Heart and circulatory physiology.